These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4014325)

  • 21. [Mycobacterium fortuitum infection after total hip prosthesis. A report of 3 cases (author's transl)].
    Badelon O; David H; Meyer L; Radault A; Zucman J
    Rev Chir Orthop Reparatrice Appar Mot; 1979; 65(1):39-43. PubMed ID: 156387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of nontuberculous (atypical) mycobacterial infections in children and adolescents.
    Margileth AM
    Pediatr Infect Dis; 1985; 4(2):119-21. PubMed ID: 3885176
    [No Abstract]   [Full Text] [Related]  

  • 23. [Nontuberculous mycobacterial infections of the lung].
    Latshang TD; Lo Cascio CM; Russi EW
    Ther Umsch; 2011 Jul; 68(7):402-6. PubMed ID: 21728159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary Mycobacterium fortuitum infection.
    Oren B; Raz R; Hass H
    Infection; 1990; 18(2):105-6. PubMed ID: 2332244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disseminated Mycobacterium chelonei infection: response to sulfonamides.
    Tice AD; Solomon RJ
    Am Rev Respir Dis; 1979 Jul; 120(1):197-201. PubMed ID: 464378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycobacterium fortuitum infections of the mediastinum.
    Sethi GK; Simons WJ; Scott SM
    J Cardiovasc Surg (Torino); 1985; 26(3):307-9. PubMed ID: 3997975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical features of pulmonary disease caused by Mycobacterium fortuitum].
    Hagiwara E; Sekine A; Sato T; Baba T; Shinohara T; Endo T; Sogo Y; Nishihira R; Komatsu S; Matsumoto Y; Ogura T; Takahashi H
    Nihon Kokyuki Gakkai Zasshi; 2008 Oct; 46(10):788-92. PubMed ID: 19044027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium fortuitum lung abscess: resolution with prolonged trimethoprim/sulfamethoxazole therapy.
    Pacht ER
    Am Rev Respir Dis; 1990 Jun; 141(6):1599-601. PubMed ID: 2350102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefoxitin therapy for Mycobacterium fortuitum bacteremia with associated granulomatous hepatitis.
    Brannan DP; DuBois RE; Ramirez MJ; Ravry MJ; Harrison EO
    South Med J; 1984 Mar; 77(3):381-4. PubMed ID: 6422563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and management of postlaparotomy wound infection caused by
    Nagmoti MB; Kulgod SY; Narang R; Mulla RG
    Int J Mycobacteriol; 2019; 8(4):400-402. PubMed ID: 31793513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of infected bulla caused by Mycobacterium kansasii].
    Minami S; Suzuki K; Tsuyuguchi K; Mawatari H; Suzuki M; Arai T; Inoue Y; Hayashi S; Sakatani N
    Nihon Kokyuki Gakkai Zasshi; 2004 May; 42(5):440-5. PubMed ID: 15168464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disseminated cutaneous and synovial Mycobacterium marinum infection in a patient with systemic lupus erythematosus.
    Enzenauer RJ; McKoy J; Vincent D; Gates R
    South Med J; 1990 Apr; 83(4):471-4. PubMed ID: 2321074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal infection with Mycobacterium fortuitum associated with oesophageal achalasia.
    Varghese G; Shepherd R; Watt P; Bruce JH
    Thorax; 1988 Feb; 43(2):151-2. PubMed ID: 3353887
    [No Abstract]   [Full Text] [Related]  

  • 34. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.
    Wallace RJ; Hull SI; Bobey DG; Price KE; Swenson JM; Steele LC; Christensen L
    Am Rev Respir Dis; 1985 Aug; 132(2):409-16. PubMed ID: 4026065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features.
    Clegg HW; Foster MT; Sanders WE; Baine WB
    J Infect Dis; 1983 Mar; 147(3):427-33. PubMed ID: 6833792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of prolonged urinary tract infection caused by Mycobacterium fortuitum.
    Hochman I; Siegman-Igra Y; Goor Y; Cabili S
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):725-7. PubMed ID: 1425732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary infection with nontuberculous mycobacteria.
    Contreras MA; Cheung OT; Sanders DE; Goldstein RS
    Am Rev Respir Dis; 1988 Jan; 137(1):149-52. PubMed ID: 3337456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycobacterium fortuitum pulmonary infection associated with an antigen-selective defect in cellular immunity.
    Metcalf JF; John JF; Wilson GB; Fudenberg HH; Harley RA
    Am J Med; 1981 Sep; 71(3):485-92. PubMed ID: 7025623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis of the breast in a patient undergoing hemodialysis.
    Yazici O; Mescigil P; Kepenekci I; Celepli P; Sengul S; Azap A; Ertürk S
    Int Urol Nephrol; 2011 Mar; 43(1):241-4. PubMed ID: 20364402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hairy cell leukemia: association with disseminated atypical mycobacterial infection.
    Weinstein RA; Golomb HM; Grumet G; Gelmann E; Schechter GP
    Cancer; 1981 Jul; 48(2):380-3. PubMed ID: 7237406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.